Copyright
©The Author(s) 2020.
World J Gastrointest Pharmacol Ther. Nov 8, 2020; 11(5): 110-122
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Published online Nov 8, 2020. doi: 10.4292/wjgpt.v11.i5.110
Table 4 Univariate analyses for postoperative recurrence after the initial liver resection
| Factor | P value | |
| Number of LMGC | Actual number | 0.7860 |
| Multiple vs solitary | 0.9360 | |
| Timing of LMGC | Metachronous vs synchronous | 0.0906 |
| Occupation of LMGC | Bilobular vs unilobular | 0.5719 |
| The greatest dimension | Actual dimension (mm) | 0.7343 |
| Size of > 50 mm vs size of ≤ 50 mm | 0.5719 | |
| Serosal invasion (pathological T factor) | PT4 vs pT1-3 | 0.8033 |
| Curability of LR | Yes or no | 0.9999 |
| Lymphatic invasion (pathological ly factor) | Yes or no | 0.9282 |
| Vessel invasion (pathological v factor) | Yes or no | 0.9999 |
| Pathological differentiation | Tub vs others | 0.9282 |
| Pathological LN metastases | Yes or no | 0.9999 |
| Chemotherapy | Yes or no | 0.9999 |
- Citation: Yazawa T, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Tani M, Sato A, Kamada Y, Tani R, Aoyama R, Sasaki Y, Zaima M. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience. World J Gastrointest Pharmacol Ther 2020; 11(5): 110-122
- URL: https://www.wjgnet.com/2150-5349/full/v11/i5/110.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v11.i5.110